Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent Toxicity.

ABSTRACT: We recently reported a 2-aminoimidazole-based antibiotic adjuvant that reverses colistin resistance in two species of Gram-negative bacteria. Mechanistic studies in Acinetobacter baumannii demonstrated that this compound downregulated the PmrAB two-component system and abolished a lipid A modification that is required for colistin resistance. We now report the synthesis and evaluation of two separate libraries of substituted 2-aminoimidazole analogues based on this parent compound. From these libraries, a new small molecule was identified that lowers the minimum inhibitory concentration of colistin by up to 32-fold greater than the parent compound while also displaying less inherent bacterial effect, thereby minimizing the likelihood of resistance evolution.

SUBMITTER: Brackett CM 

PROVIDER: S-EPMC4941826 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature